140 related articles for article (PubMed ID: 34335822)
1. Combination of Xuesaitong and Aspirin Based on the Antiplatelet Effect and Gastrointestinal Injury: Study Protocol for a Randomized Controlled Noninferiority Trial.
Zhu BC; Xue CM; Lang R; Weng WL; Wang XJ; Lei ZZ; Zhang SS; Yang WH; Zhang WT; Hua GD
Evid Based Complement Alternat Med; 2021; 2021():5552506. PubMed ID: 34335822
[TBL] [Abstract][Full Text] [Related]
2. To study the mechanism of panax notoginseng in the treatment of aspirin resistance in the secondary prevention of stroke based on TLR4/MyD88/NF-κB signaling pathway: A study protocol.
Wang H; Yuan J; Wang Y; Chen J
Medicine (Baltimore); 2022 Dec; 101(50):e31919. PubMed ID: 36550905
[TBL] [Abstract][Full Text] [Related]
3. Research on the mechanism of drug-drug interaction between salvianolate injection and aspirin based on the metabolic enzyme and PK-PD model: study protocol for a PK-PD trial.
Zhang W; Zhu B; Cao W; Li R; Wang S; Gao R
Trials; 2018 Sep; 19(1):491. PubMed ID: 30217228
[TBL] [Abstract][Full Text] [Related]
4. Panax notoginseng preparation plus aspirin
Dai L; Zhang Y; Jiang Y; Chen K
Front Pharmacol; 2022; 13():1015048. PubMed ID: 36569332
[No Abstract] [Full Text] [Related]
5. Network pharmacology-based identification of protective mechanism of Panax Notoginseng Saponins on aspirin induced gastrointestinal injury.
Zhu B; Zhang W; Lu Y; Hu S; Gao R; Sun Z; Chen X; Ma J; Guo S; Du S; Li P
Biomed Pharmacother; 2018 Sep; 105():159-166. PubMed ID: 29857294
[TBL] [Abstract][Full Text] [Related]
6. Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial.
Li J; Ju J; Chen Z; Liu J; Lu F; Gao R; Xu H
Trials; 2018 Feb; 19(1):93. PubMed ID: 29415754
[TBL] [Abstract][Full Text] [Related]
7. Influence of cardiopulmonary exercise test on platelet function in patients with coronary artery diseases on antiplatelet therapy.
Yin C; Wang Y; Mo C; Yue Z; Sun Y; Hu D
BMC Cardiovasc Disord; 2022 Mar; 22(1):87. PubMed ID: 35246028
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based oral antiplatelet therapy among hospitalized Chinese patients with acute myocardial infarction: results from the Chinese acute myocardial infarction registry.
Tang X; Liu L; Yang J; Gao Z; Zhao X; Qiao S; Gao R; Wang Z; Yuan J; Yang Y
BMC Cardiovasc Disord; 2021 Jun; 21(1):299. PubMed ID: 34126921
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antiplatelet effect and tolerability of clopidogrel resinate with clopidogrel bisulfate in patients with coronary heart disease (CHD) or CHD-equivalent risks: a phase IV, prospective, double-dummy, parallel-group, 4-week noninferiority trial.
Suh JW; Seung KB; Gwak CH; Kim KS; Hong SJ; Park TH; Kim SH; Choi YJ; Joo SJ; Tahk SJ; Kim HS
Clin Ther; 2011 Aug; 33(8):1057-68. PubMed ID: 21816478
[TBL] [Abstract][Full Text] [Related]
10. Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial.
Baos S; Underwood W; Culliford L; Reeves BC; Rogers CA; Bowles R; Johnson T; Baumbach A; Mumford A
Trials; 2017 Nov; 18(1):529. PubMed ID: 29121979
[TBL] [Abstract][Full Text] [Related]
11. Clinical Study for Safety Evaluation of GXN Tablets Combined with Aspirin in Long-Term Treatment of Coronary Heart Disease.
Zi M; Li R; Lu F; Li Q; Zhao Y; Jia H; Sun M; Yang Q; Qiu P; Wei E; Wang S; Li R; Zhang W; Cao W; Li Y; Xu H; Gao R
Evid Based Complement Alternat Med; 2021; 2021():6658704. PubMed ID: 34211572
[TBL] [Abstract][Full Text] [Related]
12. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
Sharma A; Sharma C; Raina S; Singh B; Dadhwal DS; Dogra V; Gupta S; Bhandari S; Sood V
Trials; 2021 Jul; 22(1):451. PubMed ID: 34266452
[TBL] [Abstract][Full Text] [Related]
13. Drug-drug interactions between salvianolate injection and aspirin based on their metabolic enzymes.
Cao W; Yang Q; Zhang W; Xu Y; Wang S; Wu Y; Zhao Y; Guo Z; Li R; Gao R
Biomed Pharmacother; 2021 Mar; 135():111203. PubMed ID: 33401223
[TBL] [Abstract][Full Text] [Related]
14. [Effect of Radix notoginseng saponins on platelet activating molecule expression and aggregation in patients with blood hyperviscosity syndrome].
Wang J; Xu J; Zhong JB
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Apr; 24(4):312-6. PubMed ID: 15143716
[TBL] [Abstract][Full Text] [Related]
15. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
[TBL] [Abstract][Full Text] [Related]
16. Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.
Hahn JY; Song YB; Oh JH; Chun WJ; Park YH; Jang WJ; Im ES; Jeong JO; Cho BR; Oh SK; Yun KH; Cho DK; Lee JY; Koh YY; Bae JW; Choi JW; Lee WS; Yoon HJ; Lee SU; Cho JH; Choi WG; Rha SW; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Lee SH; Gwon HC;
JAMA; 2019 Jun; 321(24):2428-2437. PubMed ID: 31237645
[TBL] [Abstract][Full Text] [Related]
17. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
Thompson PL; Verheugt FW
Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
[TBL] [Abstract][Full Text] [Related]
18. A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery stenosis-Extended Antiplatelet Monotherapy (HOST-EXAM) trial.
Lee H; Koo BK; Park KW; Shin ES; Lim SW; Rha SW; Bae JW; Jeon DW; Oh SK; Hur SH; Kim BS; Lee JH; Park TH; Lee NH; Kim HS;
Am Heart J; 2017 Mar; 185():17-25. PubMed ID: 28267471
[TBL] [Abstract][Full Text] [Related]
19. Optimal antiplatelet therapy for prevention of gastrointestinal injury evaluated by ANKON magnetically controlled capsule endoscopy: Rationale and design of the OPT-PEACE trial.
Li Y; Wang X; Bao D; Liao Z; Li J; Han X; Wang H; Xu K; Li Z; Stone GW; Han Y
Am Heart J; 2020 Oct; 228():8-16. PubMed ID: 32745734
[TBL] [Abstract][Full Text] [Related]
20. Individualized mobile health interventions for cardiovascular event prevention in patients with coronary heart disease: study protocol for the iCARE randomized controlled trial.
Chen Y; Ji M; Wu Y; Deng Y; Wu F; Lu Y
BMC Cardiovasc Disord; 2021 Jul; 21(1):340. PubMed ID: 34256698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
